Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group.
| Autor: | Ajani JA, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, Rodrigues A, Fodor M, Chao Y, Voznyi E, Marabotti C, Van Cutsem E, V-325 Study Group |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 8/1/2007, Vol. 25 Issue 22, p3205-3209, 5p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|